Researchers from the UC Davis Center for Healthcare Policy and Research examined the potential long-term risks of opioid dose tapering. They found that patients on stable but higher-dose opioid ...

Please provide your email address to receive an email when new articles are posted on . Half-dose conventional synthetic DMARDs are inferior to stable-dose regimens for preventing flares during a ...

Manchester — Two-thirds of patients with rheumatoid arthritis (RA) who previously reached sustained disease control on tumour necrosis factor inhibitors (TNFi) maintain disease control for 1 year ...

Patients with rheumatoid arthritis (RA) in remission who tapered and then fully stopped either conventional synthetic disease-modifying antirheumatic drug (csDMARD) or tumor necrosis factor (TNF) ...

In a study published Aug. 3 in JAMA, a team of UC Davis Health researchers examined the potential risks of opioid dose tapering. Their study found that patients on stable opioid therapy who had their ...

Please provide your email address to receive an email when new articles are posted on . Researchers said the study raises questions about the “potential harms of tapering,” but the interpretation is ...

Rapid dosage drops can trigger bipolar episodes. Learn one expert’s method for minimizing risk and withdrawing safely. We ...

Aug. 3 (UPI) --Rapidly tapering patients off highly addictive opioid pain medications after long-term use at stable doses places them at increased risk for overdoses and mental health "crises," a ...

Researchers from the UC Davis Center for Healthcare Policy and Research examined the potential long-term risks of opioid dose tapering. They found that patients on stable but higher-dose opioid ...

For patients with severe eosinophilic asthma controlled on bevacizumab, tapering of inhaled corticosteroids (ICS) is feasible and is not associated with worse asthma control, according to a study ...

Gradual withdrawal of glucocorticoids was successful among patients with systemic lupus erythematosus (SLE) after 2 years of clinically quiescent disease, without an increased likelihood of flares, ...

A new study suggests that the increased rates of overdose and mental health crisis observed during the first year after opioid dose tapering persist through the second year. Does dose reduction for ...